Trump Nominates DOE Science Undersecretary

The president has nominated an investment banker for the role.

Written byDiana Kwon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JSQUISHThe White House announced today (July 12) that President Donald Trump has nominated Paul Dabbar, an investment banker with J.P. Morgan Chase, as the undersecretary for science for the Department of Energy (DOE).

According to the statement, Dabbar is the head of Energy Mergers and Acquisitions at J.P. Morgan, and has “investment experience across all energy sectors including solar, wind, geothermal, distributed-generation, utility, LNG [liquefied natural gas], pipeline, oil & gas, trading, energy technology, and has also led the majority of all nuclear transactions.” Currently, he is also on the DOE’s Environmental Management Advisory Board.

The previous DOE science undersecretary, Franklin “Lynn” Orr, a chemical engineer and a professor at Stanford University, left the position in January. “Under former President Barack Obama, DOE’s science undersecretary oversaw the department’s $5 billion Office of Science, as well as other offices, including those involved in energy efficiency, renewable energy, fossil energy, and nuclear power,” Science reports. “It is not clear how ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies